![Evaluation of bleeding risk in patients with renal impairment treated with Fondaparinux (Arixtra) Metwali HH, Aseeri MA, Mahmoud A, Alsaeed AS, Albdelwahab ME, Salam A, Abulezz R - J Appl Hematol Evaluation of bleeding risk in patients with renal impairment treated with Fondaparinux (Arixtra) Metwali HH, Aseeri MA, Mahmoud A, Alsaeed AS, Albdelwahab ME, Salam A, Abulezz R - J Appl Hematol](https://www.jahjournal.org/articles/2016/7/4/images/JApplHematol_2016_7_4_131_198518_t1.jpg)
Evaluation of bleeding risk in patients with renal impairment treated with Fondaparinux (Arixtra) Metwali HH, Aseeri MA, Mahmoud A, Alsaeed AS, Albdelwahab ME, Salam A, Abulezz R - J Appl Hematol
![PDF] Balancing thromboembolic risk against vitamin K antagonist-related bleeding and accelerated calcification: is fondaparinux the Holy Grail for end-stage renal disease patients with atrial fibrillation? | Semantic Scholar PDF] Balancing thromboembolic risk against vitamin K antagonist-related bleeding and accelerated calcification: is fondaparinux the Holy Grail for end-stage renal disease patients with atrial fibrillation? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a9ea7736b160331cf389dd76973108f5c3a5194d/3-Table1-1.png)
PDF] Balancing thromboembolic risk against vitamin K antagonist-related bleeding and accelerated calcification: is fondaparinux the Holy Grail for end-stage renal disease patients with atrial fibrillation? | Semantic Scholar
![BUY fondaparinux sodium (fondaparinux sodium) 2.5 mg/.5mL from GNH India at the best price available. BUY fondaparinux sodium (fondaparinux sodium) 2.5 mg/.5mL from GNH India at the best price available.](https://www.gnhindia.com/wp-content/uploads/2020/05/setid58789e3d-e5bc-4c2e-a527-495a252fcecdname54-06.jpg)
BUY fondaparinux sodium (fondaparinux sodium) 2.5 mg/.5mL from GNH India at the best price available.
![Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison - The Lancet Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2119418791/2093590429/gr1.gif)
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison - The Lancet
![Frontiers | Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study Frontiers | Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study](https://www.frontiersin.org/files/Articles/569567/fmed-07-569567-HTML-r1/image_m/fmed-07-569567-g001.jpg)
Frontiers | Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study
![WO2003041722A1 - Use of specific dose of fondaparinux sodium for the treatment of acs - Google Patents WO2003041722A1 - Use of specific dose of fondaparinux sodium for the treatment of acs - Google Patents](https://patentimages.storage.googleapis.com/76/cc/c2/cb98e3b3298ae7/imgf000006_0001.png)